FCMI

Foresite Capital Management II Portfolio holdings

AUM $29.2M
This Quarter Return
+14.55%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$233M
AUM Growth
+$233M
Cap. Flow
+$8.99M
Cap. Flow %
3.86%
Top 10 Hldgs %
99.02%
Holding
13
New
4
Increased
3
Reduced
5
Closed
–

Top Buys

1
DERM
Dermira, Inc.
DERM
$6.32M
2
AIMT
Aimmune Therapeutics, Inc.
AIMT
$3.4M
3
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
$2.64M
4
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
$1.3M
5
NTRA icon
Natera
NTRA
$450K

Top Sells

1
NSTG
NanoString Technologies, Inc.
NSTG
$3.71M
2
LRMR icon
Larimar Therapeutics
LRMR
$999K
3
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
$819K
4
AERI
Aerie Pharmaceuticals, Inc.
AERI
$78.1K
5
NVET
Nexvet Biopharma plc Ordinary Shares
NVET
$68.3K

Sector Composition

1 Healthcare 29.47%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AIMT
1
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$86.8M 37.22%
3,992,517
+156,687
+4% +$3.4M
AERI
2
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$71.3M 30.6%
1,573,026
-1,723
-0.1% -$78.1K
EPZM
3
DELISTED
Epizyme, Inc
EPZM
$26.5M 11.35%
1,543,118
+16,481
+1% +$283K
ALDR
4
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$19.9M 8.53%
956,041
-39,355
-4% -$819K
NSTG
5
DELISTED
NanoString Technologies, Inc.
NSTG
$9.79M 4.2%
492,539
-186,494
-27% -$3.71M
DERM
6
DELISTED
Dermira, Inc.
DERM
$6.32M 2.71%
+185,294
New +$6.32M
NVET
7
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
$3.41M 1.46%
877,134
-17,561
-2% -$68.3K
JNCE
8
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$2.64M 1.13%
+119,912
New +$2.64M
OREX
9
DELISTED
Orexigen Therapeutics, Inc.
OREX
$2.14M 0.92%
622,013
+79,258
+15% +$273K
LRMR icon
10
Larimar Therapeutics
LRMR
$322M
$2.1M 0.9%
449,464
-214,316
-32% -$999K
BLCM
11
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$1.3M 0.56%
+105,000
New +$1.3M
XLRN
12
DELISTED
Acceleron Pharma Inc.
XLRN
$527K 0.23%
19,910
– –
NTRA icon
13
Natera
NTRA
$23.1B
$450K 0.19%
+50,737
New +$450K